Binaschi M - Search Results

1

Characterization of a topoisomerase II gene rearrangement in a human small-cell lung cancer cell line.

Binaschi M, Giaccone G, Gazdar AF, De Isabella P, Ricotti GC, Capranico G, Zunino F. Binaschi M, et al. J Natl Cancer Inst. 1992 Nov 18;84(22):1710-6. doi: 10.1093/jnci/84.22.1710. J Natl Cancer Inst. 1992. PMID: 1331483

2

Relationships among tumor responsiveness, cell sensitivity, doxorubicin cellular pharmacokinetics and drug-induced DNA alterations in two human small-cell lung cancer xenografts.

Pratesi G, Capranico G, Binaschi M, De Isabella P, Pilotti S, Supino R, Zunino F. Pratesi G, et al. Among authors: binaschi m. Int J Cancer. 1990 Oct 15;46(4):669-74. doi: 10.1002/ijc.2910460420. Int J Cancer. 1990. PMID: 1976600

3

Evidence of DNA topoisomerase II-dependent mechanisms of multidrug resistance in P388 leukemia cells.

De Isabella P, Capranico G, Binaschi M, Tinelli S, Zunino F. De Isabella P, et al. Among authors: binaschi m. Mol Pharmacol. 1990 Jan;37(1):11-6. Mol Pharmacol. 1990. PMID: 2153905

4

Comparison of DNA cleavage induced by etoposide and doxorubicin in two human small-cell lung cancer lines with different sensitivities to topoisomerase II inhibitors.

Binaschi M, Capranico G, De Isabella P, Mariani M, Supino R, Tinelli S, Zunino F. Binaschi M, et al. Int J Cancer. 1990 Feb 15;45(2):347-52. doi: 10.1002/ijc.2910450223. Int J Cancer. 1990. PMID: 2154411

5

Mechanism of action of DNA topoisomerase inhibitors.

Binaschi M, Zunino F, Capranico G. Binaschi M, et al. Stem Cells. 1995 Jul;13(4):369-79. doi: 10.1002/stem.5530130408. Stem Cells. 1995. PMID: 7549896 Review.

6

MRP gene overexpression in a human doxorubicin-resistant SCLC cell line: alterations in cellular pharmacokinetics and in pattern of cross-resistance.

Binaschi M, Supino R, Gambetta RA, Giaccone G, Prosperi E, Capranico G, Cataldo I, Zunino F. Binaschi M, et al. Int J Cancer. 1995 Jul 4;62(1):84-9. doi: 10.1002/ijc.2910620116. Int J Cancer. 1995. PMID: 7601572

7

A study of cross-resistance pattern and expression of molecular markers of multidrug resistance in a human small-cell lung-cancer cell line selected with doxorubicin.

Supino R, Binaschi M, Capranico G, Gambetta RA, Prosperi E, Sala E, Zunino F. Supino R, et al. Among authors: binaschi m. Int J Cancer. 1993 May 8;54(2):309-14. doi: 10.1002/ijc.2910540224. Int J Cancer. 1993. PMID: 8098017

8

Influence of structural modifications at the 3' and 4' positions of doxorubicin on the drug ability to trap topoisomerase II and to overcome multidrug resistance.

Capranico G, Supino R, Binaschi M, Capolongo L, Grandi M, Suarato A, Zunino F. Capranico G, et al. Among authors: binaschi m. Mol Pharmacol. 1994 May;45(5):908-15. Mol Pharmacol. 1994. PMID: 8190107

9

Irreversible and reversible topoisomerase II DNA cleavage stimulated by clerocidin: sequence specificity and structural drug determinants.

Binaschi M, Zagotto G, Palumbo M, Zunino F, Farinosi R, Capranico G. Binaschi M, et al. Cancer Res. 1997 May 1;57(9):1710-6. Cancer Res. 1997. PMID: 9135013

10

Relationship between lethal effects and topoisomerase II-mediated double-stranded DNA breaks produced by anthracyclines with different sequence specificity.

Binaschi M, Capranico G, Dal Bo L, Zunino F. Binaschi M, et al. Mol Pharmacol. 1997 Jun;51(6):1053-9. doi: 10.1124/mol.51.6.1053. Mol Pharmacol. 1997. PMID: 9187272

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

55 results

Search Page

Filters